Plasma Derivatives

Plasma derivatives products

Based on its accumulated experience and technological power, Green Cross develops biomedicines required for the healthy development of humans and society as a whole. Currently focusing on the development of more advanced manufacturing technologies, Green Cross is growing into a global leader in the field of plasma-derivatives.

Plasma-derivatives are special medicines requiring high-level technology and know-how. They are made by separating plasma proteins into components and refining them. Green Cross provides safe plasma-derivatives by applying the most advanced virus inactivation methods, including nano-filtration and solvent detergent.

GCBT will provide plasma-derived products, including intravenous immunoglobulin (IVIG), for the US and Canadian markets. The plant will also produce albumin for the Canadian and Chinese markets.

GCBT-plasma-derivatives
Back to Top